Cornerstone Planning Group’s ANI Pharmaceuticals ANIP Stock Holding History

Cornerstone Planning Group’s Portfolio ANIP Stock Details ANIP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$698	Hold	9	–	–	﹤0.01%	1595
2026 Q1	$762	Hold	9	–	–	﹤0.01%	1535
2025 Q4	$716	Hold	9	–	–	﹤0.01%	1429
2025 Q3	$827	Hold	9	–	–	﹤0.01%	1361
2025 Q2	$593	Hold	9	–	–	﹤0.01%	1248
2025 Q1	$615	Hold	9	–	–	﹤0.01%	1238
2024 Q4	$544	Buy	+9	New	+$517	﹤0.01%	1109

Other funds holding ANIP

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

SCM

Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

TCM

Tang Capital Management San Diego, California $2.2B AUM 156.35% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

GACM

Global Alpha Capital Management Montreal, Quebec, Canada $1.67B AUM 35.09% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Cornerstone Planning Group's ANIP Position: Q2 2026 in Review

Cornerstone Planning Group held its ANI Pharmaceuticals (ANIP) position steady in Q2 2026 at 9 shares worth $698. The position accounts for ﹤0.01% of the portfolio, ranked #1595.

Cornerstone Planning Group first reported a position in ANIP in Q4 2024 and has held it in 7 quarters since. The position peaked at $827 in Q3 2025. 308 funds tracked by Wall St. Rank hold ANIP as of Q2 2026.

Cornerstone Planning Group held 9 shares of ANI Pharmaceuticals worth $698 as of Q2 2026.
Cornerstone Planning Group left its ANI Pharmaceuticals share count unchanged in Q2 2026.
ANI Pharmaceuticals made up ﹤0.01% of Cornerstone Planning Group's portfolio in Q2 2026, its #1595 holding.
Cornerstone Planning Group first reported a position in ANI Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
Cornerstone Planning Group's ANI Pharmaceuticals position peaked at $827 in Q3 2025.
308 funds tracked by Wall St. Rank held ANI Pharmaceuticals as of Q2 2026.

Based on Cornerstone Planning Group's 13F filing for Q2 2026, filed 29 Jul 2026.